| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.21T | 1.03T | 1.03T | 1.03T | 761.82B |
| Gross Profit | 130.44B | 121.25B | 129.62B | 125.90B | 90.72B |
| EBITDA | 46.53B | 43.29B | 71.77B | 64.14B | 40.77B |
| Net Income | 27.77B | 25.28B | 48.07B | 41.03B | 25.80B |
Balance Sheet | |||||
| Total Assets | 700.89B | 556.44B | 552.24B | 517.62B | 362.58B |
| Cash, Cash Equivalents and Short-Term Investments | 54.39B | 48.53B | 38.71B | 37.57B | 25.17B |
| Total Debt | 77.49B | 75.92B | 64.86B | 55.32B | 59.16B |
| Total Liabilities | 411.77B | 294.96B | 295.82B | 309.86B | 182.82B |
| Stockholders Equity | 278.93B | 252.41B | 244.31B | 199.79B | 170.13B |
Cash Flow | |||||
| Free Cash Flow | 17.36B | 22.57B | 38.58B | 37.90B | -16.47B |
| Operating Cash Flow | 18.77B | 24.23B | 39.95B | 38.90B | -15.53B |
| Investing Cash Flow | -1.31B | -7.96B | -18.46B | -869.00M | -1.65B |
| Financing Cash Flow | -15.16B | -5.84B | -23.01B | -27.10B | 14.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥74.02B | 8.02 | ― | 2.87% | 50.78% | 26.58% | |
73 Outperform | ¥72.34B | 9.45 | 5.37% | 3.41% | -1.40% | 13.91% | |
71 Outperform | ¥544.93B | 14.85 | ― | 2.87% | 17.41% | 10.46% | |
62 Neutral | ¥95.90B | 7.40 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥443.11B | 19.76 | 5.77% | 3.28% | 5.30% | -4.93% | |
50 Neutral | ¥128.47B | -7.98 | ― | 2.45% | 1.60% | -74.21% |